0

COSMEGEN از شرکت RECORDATI RARE

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COSMEGEN از شرکت RECORDATI RARE

New Drug Application (NDA): 050682

Company: RECORDATI RARE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COSMEGEN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription

AP

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
12/10/1964 ORIG-1 Approval

Type 1 – New Molecular Entity

PRIORITY

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
08/15/2018 SUPPL-34 Efficacy-New Dosing Regimen

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050682s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050682Orig1s034ltr.pdf

08/15/2018 SUPPL-33 Efficacy-New Dosing Regimen

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050682s033lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/050682Orig1s033ltr.pdf

04/07/2015 SUPPL-31 Manufacturing (CMC)

Label is not available on this site.

02/03/2012 SUPPL-30 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050682s029,s030ltr.pdf

02/03/2012 SUPPL-29 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/050682s029,s030ltr.pdf

03/13/2009 SUPPL-25 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050682s025lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/050682s025ltr.pdf

08/17/2005 SUPPL-22 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/050682s022ltr.pdf

11/30/2004 SUPPL-21 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/50682s021ltr.pdf

03/19/2003 SUPPL-20 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/50682slr020ltr.pdf

10/28/2002 SUPPL-19 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/50682slr019ltr.pdf

02/14/2001 SUPPL-18 Manufacturing (CMC)-Control

Label is not available on this site.

01/22/2001 SUPPL-17 Labeling

Label is not available on this site.

02/08/1999 SUPPL-16 Manufacturing (CMC)-Control

Label is not available on this site.

05/22/1998 SUPPL-15 Manufacturing (CMC)-Control

Label is not available on this site.

03/13/1998 SUPPL-14 Manufacturing (CMC)

Label is not available on this site.

06/07/2000 SUPPL-13 Labeling

Label is not available on this site.

06/06/1997 SUPPL-12 Manufacturing (CMC)-Control

Label is not available on this site.

02/14/1996 SUPPL-11 Manufacturing (CMC)

Label is not available on this site.

02/18/1997 SUPPL-10 Labeling

Label is not available on this site.

02/17/1997 SUPPL-9 Labeling

Label is not available on this site.

03/22/1988 SUPPL-7 Labeling

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
08/15/2018 SUPPL-34

Efficacy-New Dosing Regimen

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050682s034lbl.pdf
08/15/2018 SUPPL-33

Efficacy-New Dosing Regimen

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/050682s033lbl.pdf
02/03/2012 SUPPL-30

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf
02/03/2012 SUPPL-29

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/050682s029s030lbl.pdf
03/13/2009 SUPPL-25

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050682s025lbl.pdf

COSMEGEN

INJECTABLE;INJECTION; 0.5MG/VIAL

TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
COSMEGEN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription Yes AP 050682 RECORDATI RARE
DACTINOMYCIN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription No AP 203385 AUROMEDICS PHARMA
DACTINOMYCIN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription No AP 207232 HISUN PHARM HANGZHOU
DACTINOMYCIN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription No AP 213463 MEITHEAL
DACTINOMYCIN DACTINOMYCIN 0.5MG/VIAL INJECTABLE;INJECTION Prescription No AP 203999 XGEN PHARMS
بخوانید  CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE از شرکت MYLAN PHARMS INC
برچسب‌ها:

نظرات کاربران